Journal Information
Vol. 40. Issue 8.
Pages 386 (August 2004)
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D.R. Shalinsky, J. Brekken, H. Zou.
Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non small cell lung cancer tumors: single agent and combination chemotherapy studies.
Clin Cancer Res, 5 (1999), pp. 1905-1917
[2.]
C. Richardson, R. Sharma, G. Cox, K. O'Byrne.
Epidermal growth factor receptor and cyclooxygenase- 2 in non-small cell lung cancer: potential targets for chemoprevention and treatment.
Lung Cancer, 39 (2003), pp. 1-13
[3.]
I. Sampablo Lauro, J.L. Izquierdo.
¿Cuál debe ser el papel del neumólogo en el tratamiento quimioterapéutico del cáncer de pulmón?.
Arch Bronconeumol, 39 (2003), pp. 483-484
[4.]
J. Dijkman, J. Martínez González del Tio, R. Loddenkemper, K. Prowse, N. Siafakas.
Report of the working party of the “UEMS Monospeciality section of Pneumology” on training requeriments and facilities in Europe.
Eur Respir J, 7 (1994), pp. 1019-1022
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica